TABLE 1.
C. dubliniensis and C. albicans isolates used in these studies
| Species and country of isolation | No. of isolatesa | Specimen source(s) | HIV status of subject(s) sampledb | Source or reference(s) |
|---|---|---|---|---|
| C. dubliniensis | ||||
| Argentina | 1 | Oral cavity | + | 10 |
| Australia | 4 | Oral cavity | + | 4, 10, 11 |
| Belgium | 5 | Oral cavity | + | This study |
| Canada | 6 | Oral cavity | + | This study |
| Finland | 1 | Oral cavity | + | This study |
| Germany | 4 | Oral cavity | + | This study |
| Greece | 1 | Oral cavity | + | This study |
| Ireland | 52 | Oral cavity | + | This study; 11 |
| Ireland | 8 | Oral cavity | − | 2 |
| Ireland | 5 | Vaginal | − | This study; 5 |
| Spain | 9 | Oral cavity | + | This study |
| Switzerland | 6 | Oral cavity | + | 1, 10 |
| United Kingdom | 5 | Oral cavity | + | This study; 10 |
| United Kingdom | 7 | Oral cavity | − | This study |
| United Kingdom | 6 | Miscellaneousc | − | This study; 8 |
| C. albicans | ||||
| Australia | 1 | Oral cavity | + | 11 |
| Hong Kong | 6 | Oral cavity | + | This study |
| Ireland | 32 | Oral cavity | + | This study |
| 5 | Oral cavity | − | This study | |
| 20 | Vaginal | + | This study | |
| 21 | Vaginal | − | This study | |
| 8 | Blood | − | 6 | |
| United Kingdom | 1 | Oral cavity | + | This study |
| United Kingdom | 4 | Oral cavity | − | This study |
a
Each isolate was recovered from a separate individual.
b
+, positive; −, negative.
c
These included two fecal isolates and one each from a blood culture, tracheal aspirate, sputum, and postmortem lung specimens.